Goldman Sachs
WGS icon

Goldman Sachs’s GeneDx Holdings WGS Stock Holding History

Goldman Sachs’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.7M Buy
1,334,980
+114,478
+9% +$10.4M 0.01% 1138
2025
Q4 		$159M Buy
1,220,502
+52,322
+4% +$7.18M 0.02% 734
2025
Q3 		$126M Buy
1,168,180
+118,739
+11% +$12.9M 0.02% 804
2025
Q2 		$96.9M Sell
1,049,441
-39,943
-4% -$3.14M 0.01% 901
2025
Q1 		$96.5M Sell
1,089,384
-54,107
-5% -$4.69M 0.02% 803
2024
Q4 		$87.9M Buy
1,143,491
+94,847
+9% +$6.63M 0.01% 884
2024
Q3 		$44.5M Sell
1,048,644
-3,230
-0.3% -$109K 0.01% 1346
2024
Q2 		$27.5M Sell
1,051,874
-73,241
-7% -$1.39M ﹤0.01% 1617
2024
Q1 		$10.3M Sell
1,125,115
-561,716
-33% -$3.37M ﹤0.01% 2446
2023
Q4 		$4.64M Buy
1,686,831
+1,479,790
+715% +$3.44M ﹤0.01% 3225
2023
Q3 		$754K Sell
207,041
-9,770
-5% -$53.5K ﹤0.01% 4433
2023
Q2 		$1.29M Buy
216,811
+8,413
+4% +$66.6K ﹤0.01% 4174
2023
Q1 		$2.51M Sell
208,398
-201,316
-49% -$2.68M ﹤0.01% 3685
2022
Q4 		$3.57M Buy
409,714
+368,483
+894% +$8.12M ﹤0.01% 3476
2022
Q3 		$1.19M Buy
41,231
+35,453
+614% +$1.62M ﹤0.01% 4385
2022
Q2 		$241K Buy
5,778
+1,203
+26% +$81.6K ﹤0.01% 5553
2022
Q1 		$463K Buy
4,575
+1,746
+62% +$194K ﹤0.01% 5366
2021
Q4 		$416K Buy
2,829
+2,370
+516% +$529K ﹤0.01% 5488
2021
Q3 		$115K Buy
+459
New +$158K ﹤0.01% 5884
2021
Q1 		– Sell
-12,152
Closed -$4.43M – 6388
2020
Q4 		$4.43M Buy
+12,152
New +$4.23M ﹤0.01% 3094

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs's WGS Position: Q1 2026 in Review

Goldman Sachs increased its GeneDx Holdings (WGS) stake by 9.4% in Q1 2026, buying an estimated $10.4M and bringing the position to 1,334,980 shares worth $85.7M. The position accounts for 0.01% of the portfolio, ranked #1138.

Goldman Sachs first reported a position in WGS in Q4 2020 and has held it in 20 quarters since. The position peaked at $159M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Goldman Sachs held 1,334,980 shares of GeneDx Holdings worth $85.7M as of Q1 2026.
  • Goldman Sachs bought 114,478 GeneDx Holdings shares in Q1 2026, an estimated $10.4M.
  • GeneDx Holdings made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1138 holding.
  • Goldman Sachs first reported a position in GeneDx Holdings in Q4 2020 and has held it in 20 quarters since.
  • Goldman Sachs's GeneDx Holdings position peaked at $159M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.